Environmental Scan of Genetic and Genomic Biomarker Testing Assessment Frameworks, Processes, and Inventories in Cancer Care 

Precision medicine technologies, including genetic and genomic testing for biomarkers in cancer care, are rapidly emerging and being used in health care systems in Canada. However, approaches to evaluating and implementing biomarker testing are not standardized and vary between jurisdictions. This Environmental Scan will identify and summarize existing guiding principles, assessment criteria, decision-making processes, inventories, and other information relevant to the assessment and implementation of genetic and genomic biomarker testing in cancer care. A literature review and consultations will inform the scan.

Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and expected completion dates may change. Find out more about Projects in Progress.

The “Projects in Progress” page on the Canada's Drug Agency website is updated on a seven- to eight-day cycle. Please be advised that there may be overlap between when a new report is posted online and when the section is updated. View our current Projects in Progress.